Ignite Creation Date:
2024-05-06 @ 1:00 AM
Last Modification Date:
2024-10-26 @ 10:57 AM
Study NCT ID:
NCT01705639
Status:
COMPLETED
Last Update Posted:
2017-01-04
First Post:
2012-10-10
Brief Title:
Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene
Sponsor:
University of Helsinki
Organization:
University of Helsinki
Study Overview
Official Title:
Does Melatonin Treatment Affect Glucose Tolerance Among Individuals With a Variant rs10830963 of the Melatonin Receptor 1B MTNR1B Gene
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MELAG
Brief Summary:
The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants of the melatonin receptor 1B gene will be evaluated The following will be done at 0 and 3 months
OGTT
questionnaires about sleep and activity
Actigraph
Anthropometry
Blood pressure
OGTT
questionnaires about sleep and activity
Actigraph
Anthropometry
Blood pressure
Detailed Description:
httpwwwsciencedirectcomsciencearticlepiiS1550413116301607
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None